ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
May 2025
Nuclear Technology
April 2025
Fusion Science and Technology
Latest News
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”
John Slough
Fusion Science and Technology | Volume 60 | Number 2 | August 2011 | Pages 464-469
Power Plant, Demo, and FNSF | Proceedings of the Nineteenth Topical Meeting on the Technology of Fusion Energy (TOFE) (Part 2) | doi.org/10.13182/FST60-464
Articles are hosted by Taylor and Francis Online.
An intense neutron source capable of generating the characteristic flux of a fusion reactor (1-4 MW/m2) is an essential element for adequate reactor materials assessment. Based on recent experimental results involving the magneto-kinetic compression of the Field Reversed Configuration (FRC), it is believed that such a fusion based neutron source can be rapidly developed at low cost. The ability to provide a fusion plasma with the necessary radiation intensity is afforded by the considerable increase in fusion neutron yield that occurs concurrently with the large reduction in reacting plasma volume from the straightforward magnetic flux compression of an FRC plasmoid. Pulsed formation and flux compression of FRCs in a prototype device operating at 4 Hz would yield a neutron power fluence at the wall of 1 MW/m2 from a fusion plasma volume of a half liter. This is roughly a factor 106 smaller than a reactor-scale fusion plasma such as ITER, thereby dramatically reducing the cost and time for the evaluation of materials for fusion application. The required magnetic compression field and energy per pulse is less than 16 T and 100 kJ respectively.
